Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Taxotere and AC in Breast Cancer
NCT00206466Phase 2Completed
- Sponsor
- Baylor Breast Care Center
- Start
- Apr 2002
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel in breast cancer, sponsored by Baylor Breast Care Center. Primary endpoint: Gene expression profile predictive of response at 10 years. Started Apr 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00206466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206466.